According to Aspen Pharmacare's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.4675. At the end of 2023 the company had a P/S ratio of 2.04.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.04 | 43.99% |
2022 | 1.42 | -5.17% |
2021 | 1.50 | -16.22% |
2020 | 1.79 | 84.28% |
2019 | 0.9688 | -56.94% |
2018 | 2.25 | 2.15% |
2017 | 2.20 | -39.79% |
2016 | 3.66 | 22.98% |
2015 | 2.97 | 13.98% |
2014 | 2.61 | -7.61% |
2013 | 2.82 | 73.31% |
2012 | 1.63 | 53.33% |
2011 | 1.06 | -23.92% |
2010 | 1.40 | 44.69% |
2009 | 0.9655 | -3.31% |
2008 | 0.9986 | -16.04% |
2007 | 1.19 | -13.99% |
2006 | 1.38 | 35.2% |
2005 | 1.02 | 52.3% |
2004 | 0.6716 |